Latest Prostate Specific Antigen News
Following the 2012 USPSTF recommendation against PSA screening in populations, rates of radical prostatectomy and biopsy have become significantly less common.
A PSA level of 1.5 ng/mL or higher should prompt primary care physicians to refer patients to a urologist for further evaluation.
In a PREVAIL trial post hoc analysis, nearly one fourth of men on enzalutamide had radiographic progression despite non-rising PSA.
After 20 years, the prostate cancer mortality rate was 0.7% for men with a PSA level of 10 ng/mL or less and benign initial biopsy results.
Decreases in use of screening following USPSTF recommendations against routine PSA screening.
Shows the strongest correlation between biochemical recurrence and subsequent systemic progression.
The odds of developing lethal prostate cancer were increased by 6.9 to 12.6 times for men aged 40 to 59 years with higher PSA values.
LUTS is 49% more likely to develop in men with a PSA level above 6 ng/mL versus 4 ng/mL or less.
The PLCO trial's conclusion that routine PSA testing does not affect prostate cancer mortality risk could be wrong.
The odds of PSA screening were higher among blacks than non-Hispanic whites.
PSA level declined by an average of 0.68 ng/mL in the treatment group.
Older men whose clinician was a physician trainee had substantially lower prostate-specific antigen (PSA) screening rates.
The proportion of biopsied men who have complications from the procedure rose from 14% to 18% from 2005 to 2014.
This includes less frequent screening and more restrictive biopsy referral criteria.
Differential effect of 2012 USPSTF recommendations for primary care providers, urologists.
Renal and Urology News Articles
- CB-839 Drug Promising for Clear Cell, Papillary Renal Cell Cancer
- Guideline Confirmed for UTI in Children With Fever
- Survival Benefit Linked With Adjuvant RT+ADT in Lymph Node + PCa
- Reoperation Risk Highest After POP Repair With Vaginal Mesh and Sling
- AKI Is a Risk Factor for Delirium, Coma in Critically Ill
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)